Alyeska Investment Group, L.P. Eli Lilly & CO Transaction History

Alyeska Investment Group, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $56.7 Million - $71.1 Million	-78,266 Reduced 48.81%	82,078 $74.3 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $18.2 Million - $24.4 Million	-30,738 Reduced 16.09%	160,344 $125 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $100 Million - $118 Million	191,082 New	191,082 $111 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $77.6 Million - $88.4 Million	261,724 New	261,724 $84.6 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $48.4 Million - $60.1 Million	-215,222 Reduced 98.59%	3,077 $850,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $13.4 Million - $16.5 Million	60,362 Added 38.22%	218,299 $50.4 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $37,373 - $48,342	-207 Reduced 0.13%	157,937 $36.3 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $12.5 Million - $16.2 Million	-75,983 Reduced 32.45%	158,144 $29.5 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $2.86 Million - $3.78 Million	21,901 Added 10.32%	234,127 $39.5 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $31 Million - $35.9 Million	212,226 New	212,226 $31.4 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.